Rulemaking in the US

Our mandate was to “evaluate the implications for Europe of the development in United States of a risk-based ethical review system for medical research aimed at replacing the Common Rule“(the Common Rule is the popular phrase for The Federal Policy for the Protection of Human Subjects in research). We have solved this task by describing the new legislation and review system in the US and how this affects biobanking and research on health data. We have further looked at the American research ethical debate on the new Common Rule. Finally, we have discussed pros and cons of the American research regulation compared to the typical European one. The project was conducted in the period of April 2017 to June 2018.

Related Organizations

Norwegian University of Science and Technology
Norway

Keywords

biobanking, health data, medical research

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average